Kaiser Permanente Northern California’s Division of Research has received a $5 million grant from the American Heart Association to study how AI can improve screening and treatment for cardiovascular disease.
The funding, announced in a July 29 news release, will support a multi-center clinical trial led by David Ouyang, MD, a research scientist at the Division of Research and a cardiologist with The Permanente Medical Group. The trial will explore how AI can enhance the effectiveness of echocardiograms, or heart ultrasounds, in cardiac care.
The study will be conducted across four sites:
- Kaiser Permanente Northern California, with Andrew Ambrosy, MD; Ankeet Bhatt, MD; and Alan Go, MD.
- Stanford Health Center, with Alex Sandhu, MD, and Jason Hom, MD.
- Los Angeles-based Cedars-Sinai Smidt Heart Institute, with Alan Kwan, MD, and Susan Cheng, MD.
- Somerville, Mass.-based Mass General Brigham, with Long Nguyen, MD; Tracey Simon, MD; and Emily Lau, MD.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
